Magenta Therapeutics (MGTA) PT Lowered to $7 at Goldman Sachs
Tweet
Share
E-mail
Get Alerts MGTA Hot Sheet
Price: $0.70 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Goldman Sachs analyst Madhu Kumar lowered the price target on Magenta Therapeutics (NASDAQ: MGTA) to $7.00 (from $8.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rentokil Initial (RTO) PT Lowered to $35 at Oppenheimer
- Johnson & Johnson upgraded to Buy at HSBC on 'asymmetric risk and attractive upside'
- Amlogic Shanghai Co Ltd (688099:CH) PT Lowered to RMB72 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
